Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Oncology > 2026 Vol. 1 > No. 2 > 100023
Next Article Previous Article
TRANSLATIONAL PATENT   Open Access     Cite

L-proline supplementation for metabolic dysfunction-associated steatotic liver disease: A new use of a natural amino acid

  • 1.

    NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, The Fourth Hospital of Harbin Medical University, Harbin 150028, China

  • 2.

    Department of Student Affairs, The Fourth Hospital of Harbin Medical University, Harbin 150028, China

More Information
The Innovation Oncology  1(2),  https://doi.org/10.59717/j.xinn-oncol.2026.100023  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Lou T.W., Yang R.X. and Fan J.G. (2024). The global burden of fatty liver disease: The major impact of China. Hepatobiliary Surg. Nutr. 13:119−123. DOI:10.21037/hbsn-23-556

    View in Article CrossRef Google Scholar

    [2] Liu D., Wong C.C., Fu L., et al. (2018). Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target. Sci. Transl. Med. 10:eaap9840. DOI:10.1126/scitranslmed.aap9840

    View in Article CrossRef Google Scholar

    [3] Sanyal A.J., Van Natta M.L., Clark J., et al. (2021). Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385:1559−1569. DOI:10.1056/NEJMoa2029349

    View in Article CrossRef Google Scholar

    [4] Guirguis E., Dougherty J., Thornby K., et al. (2025). Resmetirom: The first food and drug administration-approved medication for nonalcoholic steatohepatitis (NASH). Ann. Pharmacother. 59:162−173. DOI:10.1177/10600280241259528

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Wu Y., Zhang C. and Liu D. (2026). L-proline supplementation for metabolic dysfunction-associated steatotic liver disease: A new use of a natural amino acid. The Innovation Oncology 1:100023. https://doi.org/10.59717/j.xinn-oncol.2026.100023
    Wu Y., Zhang C. and Liu D. (2026). L-proline supplementation for metabolic dysfunction-associated steatotic liver disease: A new use of a natural amino acid. The Innovation Oncology 1:100023. https://doi.org/10.59717/j.xinn-oncol.2026.100023

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Supplementary Information

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(76) PDF downloads(21)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.